FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Omeprazole topics
Omeprazole
Esomeprazole
Esomeprazole Magnesium Dihydrate
Benzimidazole
Someprazole
Esomeprazole Magnesium
Omeprazole Magnesium
Polymorphic
Organic Molecules
S Omeprazole
Organic Molecule
Enantiomer
Lansoprazole

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Omeprazole patents



      
           
This page is updated frequently with new Omeprazole-related patent applications. Subscribe to the Omeprazole RSS feed to automatically get the update: related Omeprazole RSS feeds. RSS updates for this page: Omeprazole RSS RSS


Date/App# patent app List of recent Omeprazole-related patents
04/02/15
20150093793
 Novel  producing metabolites from omeprazole using bacterial cytochrome p450, and composition for same patent thumbnailNovel producing metabolites from omeprazole using bacterial cytochrome p450, and composition for same
The present invention relates to a novel method for producing metabolites from omeprazole using bacterial cytochrome p450, and a composition therefor, and more specifically, to a composition and a kit for producing a 5′-hydroxyl product from omeprazole, containing bacterial cytochrome p450 bm3 (cyp102a1) or mutants thereof, and to a method for producing the same. The composition, the kit, and the method are capable of economically and highly efficiently mass-producing the 5′-hydroxyl product from the omeprazole, and thus will significantly contribute to development of a novel drug using metabolites from the omeprazole..
03/19/15
20150079169
 Controlled dosing of clopidogrel with gastric acid inhibition therapies patent thumbnailControlled dosing of clopidogrel with gastric acid inhibition therapies
The present invention provides for novel formulations of clopidogrel in combination with proton pump inhibitors (ppi) and optionally with nsaids, for use as improved antiplatelet therapies in stroke and cardiovascular indications. The invention provides the delivery of clopidogrel in pulses or waves, such that the total dose is phased/spread out over time and, advantageously, combined with omeprazole in a way to minimize the conflicting actions these two drugs may have on each other.
Pozen Inc.
03/12/15
20150073050
 Co-administration of omeprazole and eicosapentaenoic acid or a derivative thereof patent thumbnailCo-administration of omeprazole and eicosapentaenoic acid or a derivative thereof
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing triglycerides in a subject on omeprazole therapy, the method comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.. .
Amarin Pharmaceuticals Ireland Limited
02/26/15
20150057314
 Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same patent thumbnailComposition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
The present disclosure relates to pharmaceutical compositions comprising omeprazole, lansoprazole and sodium bicarbonate. Methods of using such compositions are also provided.
The Curators Of The University Of Missouri
01/08/15
20150011588
 Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid patent thumbnailNovel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease, or the symptoms associated with, or related to a gastrointestinal disorder or disease in a subject in need thereof. In one aspect, the present invention provides a pharmaceutical composition comprising a proton pump inhibiting agent and a buffering agent for oral administration and ingestion by a subject.
12/18/14
20140370088
 Compositions and methods for delivery of omeprazole plus acetylsalicylic acid patent thumbnailCompositions and methods for delivery of omeprazole plus acetylsalicylic acid
The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising acetylsalicylic acid, or pharmaceutically acceptable salt thereof, and omeprazole, or pharmaceutically acceptable salt thereof.. .
Pozen Inc.
10/23/14
20140311929
 Liquid dosage form and delivery system patent thumbnailLiquid dosage form and delivery system
A pharmaceutical dosage form comprising solid liquid components comprising solid and liquid components; the solid component comprising omeprazole as active ingredient; one or more water soluble excipients; wherein the liquid component comprises: a surfactant; water and optional further excipients.. .
09/11/14
20140255503
 Pharmaceutical composition of omeprazole patent thumbnailPharmaceutical composition of omeprazole
The present invention refers to oral solid pharmaceutical compositions comprising concentrate omeprazole pellets, processes for the preparation of the same and their use as medicaments, more particularly for the treatment and/or prophylaxis of a gastrointestinal disorder.. .
08/21/14
20140235859
 Process for the resolution of omeprazole patent thumbnailProcess for the resolution of omeprazole
The present invention relates to process for the resolution of omeprazole. The present invention further provides a novel compound of enantiomers of omeprazole cyclic amine salt and a process for preparing it.
11/14/13
20130303772
 Crystalline s-omeprazole strontium hydrate,  preparing same, and pharmaceutical composition containing same patent thumbnailCrystalline s-omeprazole strontium hydrate, preparing same, and pharmaceutical composition containing same
Disclosed are a crystalline s-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, thermostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.. .
06/13/13
20130150587

Process for the preparation of esomeprazole magnesium dihydrate


A process for preparing form a of (s)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole magnesium dihydrate, processes for preparing various intermediates useful in the preparation of form a of (s)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole magnesium dihydrate and a novel polymorphic form ii of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]thio]-1h-benzimidazole.. .
04/25/13
20130101668

Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals: oxidation of coordinated benzimidazole to omeprazole


The present invention is directed to a process for the catalytic oxidation of the thioether 5-methoxy-2-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)methylthio)-1h-benzimidazole to its sulfoxide: 5-methoxy-2-((4-methoxy-3,5-dimethyl-2-pyridinyl) methyl) methylsulfinyl)-1h-benzimidazole comprising: reacting the thioether with: 1) a transition metal catalyst; and, 2) an oxygen source; wherein the thioether is oxidized to the sulfoxide commonly known as omeprazole and wherein one of either the r and s enantiomers is formed to an enantiomeric excess.. .
03/14/13
20130064891

Pharmaceutical compositions of nsaid and acid inhibitor


The present invention relates a pharmaceutical composition comprising esomeprazole magnesium dihydrate, non-steroidal anti-inflammatory drug and one or more pharmaceutically acceptable excipients, wherein non-steroidal anti-inflammatory drug is present in two or more portions. More particularly, the invention relates to compositions comprising esomeprazole and naproxen and a process for preparation thereof.
12/31/69
20120309976


. .
12/31/69
20120215003


. .
12/31/69
20120122933


. .
12/31/69
20120095054


. .


Popular terms: [SEARCH]

Omeprazole topics: Omeprazole, Esomeprazole, Esomeprazole Magnesium Dihydrate, Benzimidazole, Someprazole, Esomeprazole Magnesium, Omeprazole Magnesium, Polymorphic, Organic Molecules, S Omeprazole, Organic Molecule, Enantiomer, Lansoprazole

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Omeprazole for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Omeprazole with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         















3.0951

2432

459291 - 0 - 50